Tranilast Suppresses the Disease Development of the Adjuvant- and Streptococcal Cell Wall-Induced Arthritis in Rats
This study explores the effects of the anti-allergic and anti-fibrotic agent tranilast on adjuvant- and streptococcal cell wall-induced arthritis in rats, animal models of rheumatoid arthritis in humans. Tranilast (150 or 300 mg/kg, twice daily) or vehicle only was administered orally to the two art...
Saved in:
Main Authors: | Toshiaki Nagate (Author), Toru Tamura (Author), Fumiyasu Sato (Author), Junji Kuroda (Author), Jun Nakayama (Author), Nobuo Shibata (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2007-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tranilast Inhibits Pulmonary Fibrosis by Suppressing TGFβ/SMAD2 Pathway
by: Kato M, et al.
Published: (2020) -
Suppression of Matrix Metalloproteinase Production in Nasal Fibroblasts by Tranilast, an Antiallergic Agent, In Vitro
by: Toshiyuki Shimizu, et al.
Published: (2005) -
Effects of tranilast on the epithelial-to-mesenchymal transition in peritoneal mesothelial cells
by: Seok Hui Kang, et al.
Published: (2019) -
Assessing the response of morphea and limited scleroderma to tranilast: a small prospective study comparing topical corticosteroids to a combination of topical corticosteroids and tranilast
by: Noakes R
Published: (2018) -
Tranilast Can be a Useful Addition to the Limited Anti-Epidermolysis Bullosa Weaponry
by: Mohammad Mahdi Parvizi, et al.
Published: (2017)